Microbiome-Targeted Therapies in Neurology

This track focuses on the role of the gut-brain axis and microbiome in neurological health and disease. Researchers are invited to submit abstracts on microbiome-targeted therapies, including probiotics, prebiotics, and dietary interventions, that influence neuroimmune and neuropharmacological outcomes. The track will explore the mechanisms by which the microbiome affects neurological function and the potential for microbiome-based treatments in conditions such as autism, depression, and multiple sclerosis. Attendees will gain insights into how manipulating the microbiome can offer novel therapeutic avenues in neurology.

    Related Conference of Microbiome-Targeted Therapies in Neurology

    March 09-10, 2026

    17th Nephrology,Renal Medicine & Renal Care

    Dubai, UAE
    March 26-27, 2026

    22nd World Nephrology Conference

    Amsterdam, Netherlands
    April 27-28, 2026

    11th World Kidney Congress

    London, UK
    June 29-30, 2026

    18th World Nephrology Summit

    Aix-en-Provence, France
    August 27-28, 2026

    30th European Nephrology Conference

    Berlin, Germany
    November 10-11, 2026

    13th World Congress on Epidemiology & Public Health

    Amsterdam, Netherlands

    Microbiome-Targeted Therapies in Neurology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in